Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents Journal Article


Authors: Giulino-Roth, L.; Keller, F. G.; Hodgson, D. C.; Kelly, K. M.
Article Title: Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents
Abstract: The outcome for children and adolescents with low risk Hodgkin lymphoma (HL) is excellent, with event-free survival >85% and overall survival >95%. Historically, however, treatment has come at the cost of significant long-term toxicity from chemotherapy, radiation or a combination of these. Recent treatment strategies have focused on maintaining high event-free and overall survival while minimizing the use of therapy associated with late effects. The strategies used to achieve this vary greatly among paediatric cooperative groups and there is no one standard treatment for children with low risk HL. This review summaries recent clinical trials in paediatric low risk HL and addresses some of the important considerations when comparing trials, including differences in the definition of low risk HL, differences in outcome among histological subtypes and varying approaches to reduce or eliminate radiation therapy. Recommendations are provided for the treatment of children with low risk HL outside the setting of a clinical trial. © 2015 John Wiley & Sons Ltd.
Keywords: adolescent; cancer survival; child; treatment response; survival rate; overall survival; prednisone; allogeneic stem cell transplantation; histopathology; review; salvage therapy; cisplatin; doxorubicin; cancer risk; treatment planning; drug targeting; cancer radiotherapy; cytarabine; methotrexate; outcome assessment; disease association; dacarbazine; progression free survival; multiple cycle treatment; etoposide; cyclophosphamide; dexamethasone; vincristine; autologous stem cell transplantation; risk factor; ifosfamide; procarbazine; vinblastine; childhood cancer; hodgkin disease; risk assessment; dosimetry; bleomycin; high risk population; navelbine; therapy; chemoradiotherapy; hodgkin lymphoma; involved field radiation therapy; human; priority journal; paediatrics
Journal Title: British Journal of Haematology
Volume: 169
Issue: 5
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2015-06-01
Start Page: 647
End Page: 660
Language: English
DOI: 10.1111/bjh.13372
PROVIDER: scopus
PUBMED: 25824371
DOI/URL:
Notes: Export Date: 3 June 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lisa Giulino Roth
    16 Roth